23 Feb uniQure
Josh Leeman, Ph.D., Vice President, Business Development, Search and Evaluation
Oct. 13 | 2:15pm | AVROBIO Ballroom
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease, and other severe genetic diseases.